CTI Clinical Trial and Consulting Services Announces Acquisition of CRS Clinical Research Services
Cincinnati, Ohio
CTI Clinical Trial and Consulting Services (CTI) announces the acquisition of CRS Clinical Research Services and CRS – Staff Leasing Services (CRS), a clinical research organization headquartered in Northern Germany. CTI will incorporate all CRS employees into its current European operations and maintain the CRS headquarters located near Hamburg, Germany. CTI is planning to augment its coverage in Germany with the opening of an additional office in the southern region of the country in the coming months.
CRS is a full service, therapeutically-focused clinical research organization, with an emphasis on phase II and phase III clinical trials. Therapeutic areas of focus include infectious disease, oncology, and autoimmune diseases. CRS has managed clinical trials for large pharmaceutical companies, biotechnology companies, and for non-profit organizations across Western Europe.
“The addition of the CRS management and research teams will significantly advance CTI’s current expansion in Europe,” says Timothy Schroeder, CTI President and CEO.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
